UNIGE document Scientific Article
previous document  unige:19043  next document
add to browser collection
Title

Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding

Authors
Jones, Tiffanny
Yeaman, Michael R.
Sakoulas, George
Yang, Soo-Jin
Proctor, Richard A.
Sahl, Hans-Georg
Xiong, Yan Q.
show hidden authors show all authors [1 - 9]
Published in Antimicrobial Agents and Chemotherapy. 2008, vol. 52, no. 1, p. 269-278
Abstract Increasingly frequent reports have described the in vivo loss of daptomycin susceptibility in association with clinical treatment failures. The mechanism(s) of daptomycin resistance is not well understood. We studied an isogenic set of Staphylococcus aureus isolates from the bloodstream of a daptomycin-treated patient with recalcitrant endocarditis in which serial strains exhibited decreasing susceptibility to daptomycin. Since daptomycin is a membrane-targeting lipopeptide, we compared a number of membrane parameters in the initial blood isolate (parental) with those in subsequent daptomycin-resistant strains obtained during treatment. In comparison to the parental strain, resistant isolates demonstrated (i) enhanced membrane fluidity, (ii) increased translocation of the positively charged phospholipid lysyl-phosphotidylglycerol to the outer membrane leaflet, (iii) increased net positive surface charge (P < 0.05 versus the parental strain), (iv) reduced susceptibility to daptomycin-induced depolarization, permeabilization, and autolysis (P < 0.05 versus the parental strain), (v) significantly lower surface binding of daptomycin (P < 0.05 versus the parental strain), and (vi) increased cross-resistance to the cationic antimicrobial host defense peptides human neutrophil peptide 1 (hNP-1) and thrombin-induced platelet microbicidal protein 1 (tPMP-1). These data link distinct changes in membrane structure and function with in vivo development of daptomycin resistance in S. aureus. Moreover, the cross-resistance to hNP-1 and tPMP-1 may also impact the capacity of these daptomycin-resistant organisms to be cleared from sites of infection, particularly endovascular foci.
Keywords *Anti-Bacterial Agents/metabolism/pharmacology/therapeutic use*Cell Membrane/chemistry/metabolism/physiologyCell Membrane Permeability*Daptomycin/metabolism/pharmacology/therapeutic use*Drug Resistance, BacterialHumansMicrobial Sensitivity TestsPhospholipids/analysisStaphylococcal Infections/*drug therapy/microbiologyStaphylococcus aureus/*drug effectsTreatment Failure
Identifiers
PMID: 17954690
Full text
Article - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://aac.asm.org/content/52/1/269.full.pdf
Structures
Research group Analyse génomique et fonctionnelle du staphylocoque doré (604)
Citation
(ISO format)
JONES, Tiffanny et al. Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. In: Antimicrobial Agents and Chemotherapy, 2008, vol. 52, n° 1, p. 269-278. https://archive-ouverte.unige.ch/unige:19043

168 hits

0 download

Update

Deposited on : 2012-03-27

Export document
Format :
Citation style :